COVID Vaccines for Kids
COVID-19 vaccines have been approved for children ages 5-11, a decision most had already anticipated. But lost in the predictability ...
America United International, Protecting Individuals Against Judicial Misconduct
Dr. Zena Crenshaw-Logal has taken what she learned as an advocate for judicial reform to launch America United International.
The Media Has Failed Healthcare
The rise in healthcare journalism has led to a rise in biased healthcare articles – with many articles written through ...
First Principles of Healthcare
First principles thinking attempts to break down complex concepts into its fundamental parts. When we apply this thinking to healthcare, ...
Moderna, a Modern Medical Company
Moderna's decision to restrict the licensing rights of its vaccine came as a surprise to many. But for those who ...
The DEA’s Long Game
The DEA recently issued a public health alert, warning of counterfeit pills. A seemingly odd alert given the DEA's restrictions ...
Vaccine or Treatment
The public perceives the pandemic through binary thinking, as though playing a zero sum game. But healthcare is not binary. ...
Abortion’s Precedent
America's regulation of abortion sets a concerning precedent for all of healthcare. As we expand healthcare coverage, we must caution against ...
What ‘Doing Research’ Really Means
A phrase we hear frequently of late, often among prominent personalities with little to no formal scientific training. We decode ...
Mixing and Matching Vaccines
The CDC might reverse course again, this time on mixing vaccine formularies. We review the science and politics underlying the ...
Modern Day Fertility Crisis
A recent report erroneously attributes decreasing fertility rates to personal choice among women, conflating economic trends with personal decisions.
Crafting a Vaccine Marketing Campaign
We see many newly minted vaccine campaigns motivating those eligible to get vaccinated. We analyze why these campaigns will fail.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more